Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

248 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Possible association of high-density lipoprotein cholesterol levels with trunk muscle deficits and decrease in energy expenditure in patients with or at risk for COPD: A pilot study.
Shirahata T, Sato H, Yogi S, Inoue K, Niitsu M, Miyazawa H, Akagami T, Soma M, Mio T, Nagata M, Nishida Y, Tanaka S, Katsukawa F, Nakamura H. Shirahata T, et al. Among authors: mio t. Respir Investig. 2022 Sep;60(5):720-724. doi: 10.1016/j.resinv.2022.06.005. Epub 2022 Jul 9. Respir Investig. 2022. PMID: 35821189 Free article.
Real-world status of multimodal treatment of Stage IIIA-N2 non-small cell lung cancer in Japan: Results from the SOLUTION study, a non-interventional, multicenter cohort study.
Horinouchi H, Murakami H, Harada H, Sobue T, Kato T, Atagi S, Kozuki T, Tokito T, Oizumi S, Seike M, Ohashi K, Mio T, Sone T, Iwao C, Iwane T, Koto R, Tsuboi M. Horinouchi H, et al. Among authors: mio t. Lung Cancer. 2024 Nov 14;199:108027. doi: 10.1016/j.lungcan.2024.108027. Online ahead of print. Lung Cancer. 2024. PMID: 39708388 Free article.
Randomized Phase II Trial of Amrubicin Plus Irinotecan Versus Cisplatin Plus Irinotecan in Chemo-naïve Patients With Extensive-Disease Small-Cell Lung Cancer: Results of the Japan Multinational Trial Organization (JMTO) LC 08-01.
Yoshioka H, Ishida T, Atagi S, Tamiya A, Nishimura T, Iwamoto Y, Kanehara M, Kim YH, Korogi Y, Tomii K, Katakami N, Komuta K, Nishikawa M, Gemma A, Yamaki K, Kawahara M, Miyakoshi C, Mio T. Yoshioka H, et al. Among authors: mio t. Clin Lung Cancer. 2024 Oct 1:S1525-7304(24)00197-9. doi: 10.1016/j.cllc.2024.09.004. Online ahead of print. Clin Lung Cancer. 2024. PMID: 39482146
Exploratory Bronchoalveolar Lavage Fluid Analyses Reveal a High Diversity of Microbiome in NTM Lung Disease and a Low Diversity of Microbiome in Bronchiectasis.
Fujita K, Yamamoto Y, Kamita M, Tanaka K, Nakabayashi T, Imakita T, Oi I, Kanai O, Mio T, Tanizawa K, Ito Y. Fujita K, et al. Among authors: mio t. Open Respir Arch. 2024 Jun 22;6(4):100351. doi: 10.1016/j.opresp.2024.100351. eCollection 2024 Oct-Dec. Open Respir Arch. 2024. PMID: 39185443 Free PMC article. No abstract available.
Treatment patterns and clinical outcomes of resectable clinical stage III non-small cell lung cancer in a Japanese real-world setting: Surgery cohort analysis of the SOLUTION study.
Tsuboi M, Murakami H, Harada H, Sobue T, Kato T, Atagi S, Tokito T, Mio T, Adachi H, Kozuki T, Sone T, Seike M, Toyooka S, Kitagawa H, Koto R, Yamazaki S, Horinouchi H. Tsuboi M, et al. Among authors: mio t. Thorac Cancer. 2024 Jul;15(20):1541-1552. doi: 10.1111/1759-7714.15305. Epub 2024 May 29. Thorac Cancer. 2024. PMID: 38812106 Free PMC article.
248 results